US Food and Drug Administration’s Adverse Event Reporting System—Highly Limited for Causal Inference in Dermatology

This viewpoint describes limitations of the US Food and Drug Administration’s Adverse Event Reporting System in dermatology literature.

Corresponding Author: Kaylin J. Beiter, MD, PhD, Department of Dermatology, University of Pennsylvania, 3400 Civic Center Blvd, Philadelphia, PA 19104 (kaylin.beiter@pennmedicine.upenn.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.